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Abstract
Background:  Atherosclerosis is a chronic progressive disease often presenting as clinical
cardiovascular disease (CVD) events. This study evaluated the characteristics of individuals with a
diagnosis of atherosclerosis and estimated the incidence of CVD events to assist in the early
identification of high-risk individuals.
Methods: Respondents to the US SHIELD baseline survey were followed for 2 years to observe
incident self-reported CVD. Respondents had subclinical atherosclerosis if they reported a
diagnosis of narrow or blocked arteries/carotid artery disease without a past clinical CVD event
(heart attack, stroke or revascularization). Characteristics of those with atherosclerosis and
incident CVD were compared with those who did not report atherosclerosis at baseline but had
CVD in the following 2 years using chi-square tests. Logistic regression model identified
characteristics associated with atherosclerosis and incident events.
Results: Of 17,640 respondents, 488 (2.8%) reported having subclinical atherosclerosis at baseline.
Subclinical atherosclerosis was associated with age, male gender, dyslipidemia, circulation
problems, hypertension, past smoker, and a cholesterol test in past year (OR = 2.2) [all p < 0.05].
Incident CVD was twice as high in respondents with subclinical atherosclerosis (25.8%) as in those
without atherosclerosis or clinical CVD (12.2%). In individuals with subclinical atherosclerosis, men
(RR = 1.77, p = 0.050) and individuals with circulation problems (RR = 2.36, p = 0.003) were at
greatest risk of experiencing CVD events in the next 2 years.
Conclusion: Self-report of subclinical atherosclerosis identified an extremely high-risk group with
a >25% risk of a CVD event in the next 2 years. These characteristics may be useful for identifying
individuals for more aggressive diagnostic and therapeutic efforts.
Background
Clinical manifestations of atherosclerosis, including coro-
nary artery disease, cerebrovascular disease, and periph-
eral arterial disease, will occur in 2 of 3 men and 1 in 2
women after age 40. [1] Almost 60% of deaths are due to
a cardiovascular disease (CVD) cause. Atherosclerosis is a
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chronic, progressive disease with a long asymptomatic
phase. [2] Subclinical atherosclerosis is a latent precursor
of clinical CVD, including myocardial infarction (MI) and
stroke. [3]
The Healthy People 2010 initiative and the Public Health
Action Plan to Prevent Heart Disease and Stroke call for
improving cardiovascular health through prevention,
detection, and treatment of risk factors, as well as preven-
tion of recurrent CVD events. [4-6] The American Heart
Association (AHA) guidelines for primary and secondary
prevention of atherosclerotic CVD provide evidence and
recommendations to assist clinicians in managing and
treating atherosclerosis. [7-9] However, evidence is lim-
ited on identifying individuals with subclinical athero-
sclerosis before a CVD event occurs, especially since
specialized diagnostic imaging is not part of routine clin-
ical practice. The purpose of the present study was to eval-
uate the self-reported characteristics and estimate the
incidence of CVD events among individuals with subclin-
ical atherosclerosis to assist in the early identification of
high-risk individuals.
Methods
A cohort of individuals with a diagnosis of subclinical
atherosclerosis with no prior history of CVD events (i.e.,
MI, stroke, or revascularization) was identified from the
Study to Help Improve Early evaluation and management
of risk factors Leading to Diabetes (SHIELD) and com-
pared with SHIELD individuals without reported athero-
sclerosis and no prior history of CVD events. SHIELD
included an initial screening phase to identify cases of
interest in the general population and a detailed baseline
survey to follow up identified cases for health status,
health knowledge, attitudes, behaviors, and treatment.
Annual follow-up surveys were administered to obtain
changes in health status, behaviors and treatment. A
detailed description of the SHIELD methodology has
been published previously. [10,11]
In brief, the screening survey was mailed to a stratified
random sample of 200,000 US households, representative
of the US population for geographic residence, household
size and income, and age of head of household. [12] The
head of household provided responses for up to 4 adult
(aged  ≥18 years) household members, resulting in a
response rate of 63.7% (127,420 households for 211,097
adults). The baseline survey was sent in 2004 to 22,001
individuals, a stratified random sample of screening
respondents, who self-reported diabetes mellitus or cardi-
ometabolic risk factors. Each respondent group was bal-
anced to be representative of that population (e.g. type 1
diabetes, type 2 diabetes) for age, gender, geographic
region, household size and income as the US population.
A response rate of 71.8% was obtained (n = 15,794).
In August 2005, the first annual follow-up survey was
mailed to all individuals selected for the baseline survey
who were still enrolled in the household panel (n =
19,613). The second follow-up survey was mailed in July
2006 to individuals who had returned either the baseline
and/or first annual questionnaires (n = 18,445). The 2005
survey had a response rate of 72%, and a 75% response
rate was obtained for the 2006 survey (n = 13,877). This
study utilized the baseline, 2005, and 2006 survey
responses.
Study Population
Respondents to the baseline survey were considered to
have subclinical atherosclerosis if they reported a diagno-
sis of narrow or blocked arteries or carotid artery disease
without a past clinical CVD event (heart disease, heart
attack, stroke, angioplasty, or heart bypass surgery) based
on the survey question of "have you ever been told by a
doctor, nurse or other health professional that you have
narrow or blocked arteries/carotid artery disease".
Respondents were also asked if they "had ever been told
that you have heart disease/heart attack, stroke/TIA or had
angioplasty, stents or surgery to clear your arteries or heart
bypass surgery". The comparison cohort for the cross-sec-
tional analysis was composed of individuals who did not
report a diagnosis of atherosclerosis (subclinical) and/or
clinical CVD (i.e. no prior history of CVD event) in the
baseline survey.
CVD Events
CVD events included heart attack, stroke, angioplasty, or
heart bypass surgery. An incident CVD event was defined
as a new CVD event reported in either the 2005 or 2006
survey without a history of a CVD event from the baseline
survey. Respondents who completed the baseline, 2005,
and 2006 surveys and responded positively to the survey
questions for atherosclerosis and CVD events (n = 7,483)
were included in the analysis of incident CVD events.
Respondents were asked to provide their weight and
height for calculation of body mass index. They also were
provided a measuring tape and instructed that while
standing, hold the tape measure loosely around their
waist at the level of their navel ("belly button") to deter-
mine waist circumference. Respondents were asked
whether they "had ever been told by a doctor, nurse or
health professional that you had circulation problems of
any kind (categorized as circulation problems) or choles-
terol problems" (categorized as dyslipidemia).
Statistical Analysis
Two separate analyses were conducted: 1) cross-sectional
analysis of baseline respondents for prevalence and char-
acteristics predicting atherosclerosis, and 2) longitudinal
analysis of incident CV events. Prevalence of subclinicalBMC Cardiovascular Disorders 2009, 9:46 http://www.biomedcentral.com/1471-2261/9/46
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atherosclerosis was calculated as the number of individu-
als reporting a diagnosis of atherosclerosis at the baseline
survey divided by the total number of respondents to the
baseline survey. Incidence of CVD events was quantified
as the number of new CVD events that were reported dur-
ing the 2 years of follow-up since the baseline survey.
Demographic features, comorbid conditions, obesity, and
smoking history of individuals with subclinical athero-
sclerosis were compared with those of the cohort who did
not report a diagnosis of atherosclerosis or previous CVD
event, using two-sided chi-square tests. Similar compari-
sons were made between respondents with atherosclerosis
and incident CVD events and the respondents with no
atherosclerosis but who had an incident CVD event.
Logistic regression analyses identified characteristics asso-
ciated with atherosclerosis without prior history of CVD
event and atherosclerosis with incident CVD events. To
identify characteristics of subclinical atherosclerosis, the
regression model included individuals with and without
subclinical atherosclerosis from the baseline survey as the
dependent variable and age, gender, race, household
income, education, geographic region, dyslipidemia, cir-
culation problems, diabetes mellitus, hypertension,
abdominal obesity, smoking, and cholesterol test in past
year as independent variables. To identify characteristics
of those with subclinical atherosclerosis who experienced
incident CVD events, the regression model included
respondents with incident CVD events and atherosclero-
sis, and age, gender, dyslipidemia, circulation problems,
diabetes mellitus, hypertension, and smoking were inde-
pendent variables. A second regression model was com-
puted with respondents with incident CVD events as the
dependent variable and atherosclerosis (yes/no), age, gen-
der, dyslipidemia, circulation problems, diabetes, hyper-
tension, and smoking as independent variables to
ascertain the value of self-reported atherosclerosis for pre-
dicting incident CVD events. Statistical significance was
set a priori at p < 0.05. The regression model c-statistic was
computed to assess goodness of fit for each model.
Results
Prevalence and Characteristics of Subclinical 
Atherosclerosis: Cross-sectional analysis
The prevalence of subclinical atherosclerosis was 2.8% in
the baseline survey (488 individuals out of 17,640
respondents). Of the 17,640 respondents, 13,596 did not
report a diagnosis of atherosclerosis or prior CVD event
and were classified as the comparison cohort, and 3,556
reported having a prior CVD event and were excluded.
Individuals reporting an atherosclerosis diagnosis were
significantly older, male, less educated, and had lower
income than respondents without atherosclerosis diagno-
sis or CVD event history (p < 0.01) (Table 1). Those
reporting subclinical atherosclerosis were also more likely
to report dyslipidemia, circulation problems, diabetes
mellitus, hypertension, abdominal obesity, a cholesterol
test in the past year, or past smoking.
In the multivariate model, subclinical atherosclerosis was
associated with advancing age, male gender, geographic
region, dyslipidemia, circulation problems, hypertension,
and smoking (Table 2). The model c-statistic was 0.964 (p
< 0.05). The odds of atherosclerosis increased by 60%
with each decade of increasing age and were twice as high
in men. Most US geographic regions had more than twice
the odds of atherosclerosis compared with the Pacific
region. Respondents with dyslipidemia were 2 times and
those with circulation problems were 5 times more likely
to have subclinical atherosclerosis than those without
these comorbid conditions. Respondents with hyperten-
sion or who were smokers (current or past) had a 40%-
74% increased odds of having atherosclerosis. Individuals
with diabetes mellitus were less likely to have atheroscle-
rosis. Race, household income, education, abdominal
obesity, and having a recent cholesterol test were not pre-
dictive of atherosclerosis (p > 0.05 for all).
Incident CVD Events and Predictors: Longitudinal analysis
A total of 7,483 respondents completed the baseline,
2005, and 2006 surveys and answered the questions on
atherosclerosis and CVD events. Among this sample of
respondents, 291 individuals had subclinical atheroscle-
rosis at baseline. Of the 291 individuals with atheroscle-
rosis, 75 (25.8%) respondents reported an incident CVD
event during the following 2 years. For the respondents
without atherosclerosis at baseline (n = 7,192), 878
(12.2%) individuals had an incident CVD event over the
2 years. The relative risk of incident CVD event after
adjustment for age, gender, comorbid conditions, and
smoking was 2.9 (95% CI: 2.2- 3.85) for those reporting
atherosclerosis.
Among individuals who experienced a CVD event during
the 2-year follow-up, a significantly greater proportion of
respondents with subclinical atherosclerosis were men,
and reported a diagnosis of dyslipidemia, circulation
problems, or hypertension compared with respondents
without subclinical atherosclerosis (p < 0.05) (Table 3).
Significantly fewer respondents with subclinical athero-
sclerosis reported diabetes mellitus compared with
respondents without clinical atherosclerosis (p < 0.05).
Most respondents (>83%) reported having a cholesterol
test in the past 12 months; however, significantly more
respondents with atherosclerosis and incident CVD event
had a cholesterol test (93%) (p < 0.05). There was no dif-
ference between respondents with subclinical atheroscle-
rosis and individuals without atherosclerosis for race,
household income, geographic region, obesity, or smok-
ing (Table 3).BMC Cardiovascular Disorders 2009, 9:46 http://www.biomedcentral.com/1471-2261/9/46
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Table 1: Comparison of respondents reporting diagnosis of atherosclerosis without history of CVD event in the baseline survey versus 
respondents with no diagnosis of atherosclerosis and no history of CVD event
Characteristics Atherosclerosis at baseline
(n = 488)
No atherosclerosis at baseline
(n = 13,596)
Age, years, mean (SD) 66.9 (12.8)* 51.3 (15.6)
Men, n (%) 276 (56.6%)* 4885 (35.9%)
Race, n (%)
White 431 (88.3%) 11,779 (86.6%)
Black 34 (7.0%) 1025 (7.5%)
Other 9 (1.8%) 384 (2.8%)
Income, n (%)
>$22,500-$39,999 259 (53.1%)* 5718 (42.1%)
$40,000-$89,999 153 (31.3%) 5144 (37.8%)
≥$90,000 76 (15.6%) 2734 (20.1%)
Geographic region, n (%)
Northeast 116 (23.8%)* 2612 (19.2%)
North Central 120 (24.6%) 3372 (24.8%)
South Atlantic 108 (22.1%) 2592 (19.1%)
South Central 85 (17.4%) 2258 (16.6%)
Mountain 19 (3.9%) 901 (6.6%)
Pacific 40 (8.2%) 1861 (13.7%)
Education, n (%)
<8th grade-High school GED 174 (35.8%)* 3949 (29.4%)
Some college-college graduate 253 (52.1%) 7660 (57.0%)
Graduate degree 59 (12.1%) 1835 (13.6%)
Dyslipidemia diagnosis, n (%) 401 (82.2%)* 6501 (47.8%)
Circulation problem diagnosis, n (%) 201 (41.2%)* 1184 (8.7%)
Diabetes diagnosis, n (%) 180 (36.9%)* 4243 (31.2%)
Hypertension diagnosis, n (%) 375 (76.8%)* 5796 (42.6%)
BMI category, n (%)
Underweight 2 (0.4%) 175 (1.3%)
Normal weight 71 (14.8%)* 2889 (21.6%)
Overweight 157 (32.7%) 3893 (29.1%)
Obese 250 (52.1%) 6417 (48.0%)
Abdominal obesity (waist circumference), n (%)† 386 (85.4%)* 8948 (70.9%)
Cholesterol test in past year, n (%)† 447 (94.3%)* 8943 (71.1%)
Smoking, n (%)
Current smoker 83 (17.4%) 2416 (18.0%)
Past smoker 235 (49.2%)* 3848 (28.7%)
Never smoked 160 (33.5%) 7147 (53.3%)
*Chi-square p < 0.01; †Group n slightly less than other variables
BMI = body mass index; CVD = cardiovascular disease; GED = general equivalency diplomaBMC Cardiovascular Disorders 2009, 9:46 http://www.biomedcentral.com/1471-2261/9/46
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Table 2: Logistic regression odds ratios for predictors of subclinical atherosclerosis (no history of prior CVD event) among SHIELD 
respondents (n = 9,672)
Characteristics Odds Ratio (95% CI) P value
Age (per year) 1.06 (1.05-1.07) <0.0001
Gender, male (female is reference group) 2.24 (1.80-2.80) <0.0001
Race, white (Other is reference group) 0.65 (0.32- 1.34) 0.24
Race, black (Other is reference group) 0.69 (0.31- 1.55) 0.37
Income, <$22,500 (≥$90,000 is reference group) 1.03 (0.72- 1.48) 0.87
Income, $22,500-$39,999 1.04 (0.73- 1.48) 0.83
Income, $40,000-$59,999 0.94 (0.65- 1.35) 0.74
Income, $60,000-$89,999 0.91 (0.63- 1.31) 0.61
Geographic region, New England (Pacific is reference group) 2.08 (1.17- 3.69) 0.013
Geographic region, Middle Atlantic 2.64 (1.71- 4.09) <0.0001
Geographic region, East North Central 2.40 (1.56- 3.69) <0.0001
Geographic region, West North Central 1.59 (0.89- 2.83) 0.12
Geographic region, South Atlantic 2.06 (1.35- 3.14) 0.001
Geographic region, East South Central 2.53 (1.48- 4.35) 0.001
Geographic region, West South Central 1.96 (1.21- 3.17) 0.006
Geographic region, Mountain 1.24 (0.67- 2.30) 0.49
Education, 8th grade (graduate degree is reference group) 1.08 (0.50- 2.32) 0.85
Education, some high school 1.04 (0.58- 1.86) 0.90
Education, high school graduate 1.29 (0.88- 1.89) 0.19
Education, some college 1.40 (0.98- 2.00) 0.06
Education, college graduate 1.05 (0.71- 1.55) 0.80
Dyslipidemia (cholesterol problems), Yes (No is reference group) 2.04 (1.56- 2.69) <0.0001
Circulation problems, Yes (No is reference group) 4.95 (3.95- 6.21) <0.0001
Diabetes, Yes (No is reference group) 0.79 (0.64- 0.99) 0.038
Hypertension, Yes (No is reference group) 1.74 (1.36- 2.24) <0.0001
Abdominal obesity (waist circumference), Yes 0.80 (0.59- 1.08) 0.14
Current smoker (Never smoked is reference group) 1.40 (1.02- 1.91) 0.037
Past smoker 1.47 (1.16-1.86) 0.002
Cholesterol test in past year (Never is reference group) 1.23 (0.35-4.32) 0.75
Model correctly identified 96.4% of atherosclerosis respondents (c-statistic).
CVD = cardiovascular diseaseBMC Cardiovascular Disorders 2009, 9:46 http://www.biomedcentral.com/1471-2261/9/46
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Multivariate logistic regression analyses of those with sub-
clinical atherosclerosis demonstrated that men with
atherosclerosis had a 77% greater risk of incident CVD
event than women (p = 0.05) (Figure 1). The risk of inci-
dent CVD events increased 2.4 times among those with
circulation problems compared with respondents without
circulation problems (p = 0.003) (Figure 1). In a second
logistic regression model which assessed the value of self-
reported atherosclerosis for predicting incident CVD
events, the presence of atherosclerosis increased the risk of
incident CVD events by 2.9 times (p < 0.001) while con-
trolling for other covariates. Increasing age (RR = 1.01 per
year), type 2 diabetes (RR = 1.37), and hypertension (RR
= 1.54) also significantly increased the risk of CVD events
in this model (p < 0.01) while gender, dyslipidemia, cir-
culation problems, and smoking were not significant pre-
dictors after adjusting for atherosclerosis status.
Table 3: Comparison of respondents with and without subclinical atherosclerosis at baseline but who experience an incident CVD 
event during 2 years of follow-up
Characteristics Atherosclerosis at baseline + incident 
CVD event
(n = 75)
No Atherosclerosis at baseline + incident 
CVD event
(n = 878)
Age, years, mean (SD) 68.1 (11.2)* 59.0 (14.5)
Male, n (%) 44 (58.7%)* 303 (34.5%)
Race, n (%)
White 64 (85.3%) 748 (85.2%)
Black 3 (4.0%) 79 (9.0%)
Other 2 (2.7%) 14 (1.6%)
Income ≥$40,000, n (%) 38 (50.7%) 408 (46.5%)
Geographic region, n (%)
Northeast 13 (17.3%) 189 (21.5%)
South Atlantic 17 (22.7%) 189 (21.5%)
Central 35 (46.7%) 357 (40.7%)
Mountain 4 (5.3%) 53 (6.0%)
Pacific 6 (8.0%) 90 (10.3%)
Dyslipidemia diagnosis, n (%) 61 (81.3%)* 549 (62.5%)
Circulation problem diagnosis, n (%) 39 (52.0%)* 136 (15.5%)
Diabetes diagnosis, n (%) 22 (29.3%)* 378 (43.1%)
Hypertension diagnosis, n (%) 60 (80.0%)* 565 (64.4%)
BMI category, n (%)
Underweight 09  ( 1 . 1 % )
Normal weight 8 (11.1%) 123 (14.4%)
Overweight 30 (41.7%) 237 (27.7%)
Obese 34 (47.2%) 486 (56.8%)
Abdominal obesity (waist 
circumference), n (%)†
43 (84.3%) 385 (79.4%)
Cholesterol test in past year, n (%)† 67 (93.1%)* 670 (83.1%)
Smoking, n (%)
Current smoker 15 (20.0%) 152 (17.5%)
Past smoker 34 (45.3%) 304 (35.1%)
Never smoked 26 (34.7%) 411 (47.4%)
*p < 0.05; †Group n slightly less than other variables
BMI = body mass index; CVD = cardiovascular diseaseBMC Cardiovascular Disorders 2009, 9:46 http://www.biomedcentral.com/1471-2261/9/46
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Discussion
Several characteristics, easily obtained through self-report,
distinguished respondents with subclinical atherosclero-
sis. Older age, male gender, and smoking were predictive
of respondents with subclinical atherosclerosis. Clinically,
having dyslipidemia, circulation problems, or hyperten-
sion was predictive of individuals with subclinical athero-
sclerosis. All of these factors can be easily and routinely
assessed by primary care physicians to detect those at risk
of subclinical atherosclerosis. If management of risk fac-
tors and treatment of comorbid conditions are imple-
mented early in the process, atherosclerosis may be
delayed and CVD events avoided. Subclinical atheroscle-
rosis was also reported more often in East Coast and Mid-
west regions than in the Pacific regions, suggesting
differential rates of imaging across the US. Several other
studies of subclinical atherosclerosis imaging, including
coronary artery calcium and carotid artery assessment,
have had similar findings. [13,14] However, the role of
these techniques in clinical practice has not yet been
defined.
The incidence of CVD events was 3 times higher in
respondents with subclinical atherosclerosis compared
with individuals without atherosclerosis after adjustment
for self-reported risk factors. Male gender, dyslipidemia,
circulation problems, and hypertension distinguished
respondents with subclinical atherosclerosis from individ-
uals without atherosclerosis who later experienced an
incident CVD event. Male gender and circulation prob-
lems were significant predictors of increased risk of inci-
dent CVD events in those reporting subclinical
atherosclerosis. Utilizing these easily obtainable charac-
teristics, physicians may identify individuals at risk for
CVD event who may be candidates for more aggressive
diagnostic and therapeutic interventions.
The prevalence of self-reported atherosclerosis was lower
in this study than that found in other studies. [15] The
Multi-ethnic Study of Atherosclerosis (MESA) reported a
prevalence of 34% based on plaque occurrence and 42%
based on calcium score. [15] It is not surprising that the
prevalence rates differ since angiographic studies are sig-
nificantly more sensitive and accurate in quantifying
atherosclerosis, especially subclinical atherosclerosis.
However, angiographic studies using computed tomogra-
phy, magnetic resonance imaging, or ultrasound and cal-
cium scores are not done widely in routine clinical
practice. The prevalence estimate of atherosclerosis from
this study is an under-estimate of the true prevalence.
There are limitations to this study that should be consid-
ered. Household panels tend to under-represent the very
wealthy and the very poor segments of the population and
do not include military or institutionalized individuals. In
addition, the determination of atherosclerosis, CVD
event, dyslipidemia, hypertension, circulation problems,
and diabetes was made based upon self-report rather than
clinical or laboratory measures. Nor was the method of
assessment available for those reporting subclinical
atherosclerosis. Fatal CVD events could not be ascertained
in this survey, so the incidence of CVD events may be
under-estimated in this study. The proportion of respond-
ents reporting a diagnosis of atherosclerosis was low in
this study; many more respondents may have had subclin-
ical atherosclerosis that was not symptomatic or diag-
nosed.
Relative risk and 95% confidence interval of an incident CVD event among individuals with subclinical atherosclerosis Figure 1
Relative risk and 95% confidence interval of an incident CVD event among individuals with subclinical athero-
sclerosis. Log likelihood = 313.8, R-square = 0.068BMC Cardiovascular Disorders 2009, 9:46 http://www.biomedcentral.com/1471-2261/9/46
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Conclusion
Atherosclerosis is a chronic and progressive disease whose
optimal prevention requires lifelong attention to diet,
exercise, smoking abstinence, and aggressive risk factor
identification and treatment. Several characteristics, easily
obtained through self-report, may distinguish respond-
ents more likely to have subclinical atherosclerosis. Self-
report of subclinical atherosclerosis identifies individuals
at very high CVD risk who are candidates for more aggres-
sive risk factor intervention, including cholesterol and
blood pressure reduction, management of blood glucose,
and weight loss.
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